Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Tscan Therapeutics Inc (TCRX)

Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
stethoscope with cartoon heart by Myriams-Fotos via Pixabay
2 "Strong Buy"-Rated Biotech Stocks With 303% to 446% Upside Potential Barchart - Tue Dec 17, 7:00AM CST

While the upside is appealing, penny stocks carry some risks.

TCRX : 2.97 (+1.37%)
$SPX : 5,930.85 (+1.09%)
SCPH : 3.39 (+2.42%)
Insider Purchase: 10% owner at $TCRX (TCRX) Buys 31,800 Shares Quiver Quantitative, Inc. - Tue Dec 17, 1:40AM CST

Capital Management LP Lynx1, a 10% owner of $TCRX ($TCRX), bought 31,800 shares of the company on 12-12-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

TCRX : 2.97 (+1.37%)
TScan Therapeutics Reports Positive Preliminary Results from ALLOHA Phase 1 Trial and Announces Upcoming Virtual KOL Event Quiver Quantitative, Inc. - Tue Dec 10, 2:58AM CST

TScan Therapeutics reports positive Phase 1 trial results for TCR-T therapies in leukemia, with a KOL event scheduled.Quiver AI SummaryTScan Therapeutics, Inc. reported promising results from the ongoing...

TCRX : 2.97 (+1.37%)
TScan Therapeutics to Present Updated Data from the Ongoing ALLOHA™ Phase 1 Heme Trial During Oral Session at the 66th American Society of Hematology Annual Meeting and Exposition GlobeNewswire - Mon Dec 9, 4:45PM CST

TCRX : 2.97 (+1.37%)
TScan Therapeutics Named a Top Place to Work by The Boston Globe for Three Consecutive Years GlobeNewswire - Thu Dec 5, 7:00AM CST

TCRX : 2.97 (+1.37%)
TScan Therapeutics to Host Virtual KOL Event Discussing ALLOHA Phase 1 Trial Data and Clinical Development Strategy Quiver Quantitative, Inc. - Mon Dec 2, 4:16PM CST

TScan Therapeutics will host a virtual KOL event on December 10 to discuss Phase 1 trial data and development strategies.Quiver AI SummaryTScan Therapeutics, Inc., a biotechnology company focused on T...

TCRX : 2.97 (+1.37%)
TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Heme Development Strategy GlobeNewswire - Mon Dec 2, 6:00AM CST

TCRX : 2.97 (+1.37%)
TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update GlobeNewswire - Tue Nov 12, 6:00AM CST

TCRX : 2.97 (+1.37%)
TScan Therapeutics Announces Upcoming Oral Presentation of Data from the ALLOHA™ Phase 1 Heme Trial at the 66th American Society of Hematology Annual Meeting and Exposition GlobeNewswire - Tue Nov 5, 8:15AM CST

TCRX : 2.97 (+1.37%)
TScan Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 39th Annual Meeting GlobeNewswire - Fri Oct 4, 8:05AM CDT

TCRX : 2.97 (+1.37%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot